A meta-analysis by investigators from FDA of three major trials of cardiac resynchronization therapy (CRT) demonstrated that women have a reduced rate of heart failure (HF) and death with CRT at a shorter QRS duration than men. Recognizing these sex-specific differences is important to improve outcomes for women with HF.
This is a preview of subscription content, log in via an institution to check access.
References
Arshad, A. et al. Cardiac resynchronization therapy is more effective in women than in men. The MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) trial. J. Am. Coll. Cardiol. 57, 813–820 (2011).
Woo, G. W. et al. Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study. J. Interv. Card. Electrophysiol. 12, 107–113 (2005).
Go, A. S. et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127, e6–e245 (2013).
Zusterzeel, R. et al. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data. JAMA Intern. Med. http://dx.doi.org/10.1001/jamainternmed.2014.2717.
Bristow, M. R. et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350, 2140–2150 (2004).
Cleland, J. G. et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med. 352, 1539–1549 (2005).
Tracy, C. M. et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation 126, 1784–1800 (2012).
Simonson, E. et al. Sex differences in the electrocardiogram. Circulation 22, 598–601 (1960).
Yancy, C. W. et al. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am. Heart. J. 157, 754–762.e2 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.B.C. serves on the medical advisory board for St. Jude Medical and is a consulting cardiologist for Medtronic. She has received speaker's fees from St. Jude Medical and Medtronic. D.N. declares no competing interests.
Rights and permissions
About this article
Cite this article
Narasimha, D., Curtis, A. Cardiac resynchronization therapy in women. Nat Rev Cardiol 11, 501–502 (2014). https://doi.org/10.1038/nrcardio.2014.113
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2014.113
- Springer Nature Limited
This article is cited by
-
Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes
Nature Reviews Cardiology (2023)